December 2012

Sun Mon Tue Wed Thu Fri Sat
            1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31          

Blogs & Sites We Read

Blog powered by Typepad

Search Site

  • Search Site
    Google

    WWW
    http://accidentalblogger.typepad.com

Counter

  • Counter

Become a Fan

Cat Quote

  • "He who dislikes the cat, was in his former life, a rat."

« "Dukh - Pain": an English - Romani poetry book | Main | Vote for me, I'm a bigot! (Joe) »

January 16, 2008

Comments

If it is all safe and healthy, why the reluctance on the part of the FDA to require marking all meat coming from cloned animals (or their progeny) to reflect that fact?

I don't know about the increased risk of mad cow disease (which has been traced to feeding animal offal to otherwise herbivorous animals) among cloned cattle but I bet there will be other defects which cause pain and suffering to the animals themselves and may well harm those who ingest their meat.

I suspect that progeny of clones have already made it into the system, without being marked as such, but that shouldn't dissuade the FDA from permitting proper labeling of such meat. Why not let the marketplace decide about the desirability of meat derived from clone progeny, just as happened with the FlavrSavr tomato, for example. Unintended consequences arose from what was thought to be a better premium variety of transgenic tomatoes:

"The failure of the Flavr Savr has been attributed to Calgene's inexperience in the business of growing and shipping tomatoes [1]. The variety of tomato Calgene started with was considered by farmers to be inferior, and insufficient resources were allocated to traditional plant breeding. As a result, Calgene's fields produced only 25-50% as many boxes per acre compared to most growers. Of these, only half as many as anticipated were large enough to be sold as premium-priced. Furthermore, much of the initial harvest was damaged during processing and shipping because ripe tomatoes are unavoidably more delicate than unripened ones. Equipment designed for handling peaches was purchased, and specialized shipping crates were developed, both at great expense. These costs along with competition from a new conventionally bred Long Shelf Life (LSL) variety prevented the Flavr Savr from becoming profitable, and Calgene was eventually bought by Monsanto which was primarily interested in Calgene's ventures into cotton and oilseed."

Incidentally, one area the FDA doesn't seem to take into account is that of epigenetic changes. (Reader Will had mentioned them briefly in a comment on the genetics post.) Because of these genetic variations, due to environmental and other unknown factors in utero, even a clone growing in a surrogate womb is not always a perfect carbon copy, accounting for around only 3 out of around 28 such clone implanting turning out viable animals, while the remaining either miscarry or develop with gross abnormalities. So, the FDA is essentially going by the 'appearance of good health' in a clone to say that its progeny are alright for introduction into the food chain, but with no real insight into epigenetic changes which might prove problematic in the long run.

I suppose we won't see 'armies of clones' soon, but we could see 'armies of clone's children', if this catches on with the breeders of livestock. If there are any issues with increased susceptibility to various diseases, whether it be mad cow from unintended exposure to rendered proteins in feed, or foot-and-mouth or other diseases, the breeder will see his stock of progeny from clones of prized animals wiped out or at least seriously decimated.

This one they are saying is only for the stem cells.

The comments to this entry are closed.